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Hic-5 Promotes the Hypertrophic Scar Myofibroblast
Phenotype by Regulating the TGF-b1 Autocrine Loop
Ganary Dabiri1, David A. Tumbarello2, Christopher E. Turner2 and Livingston Van De Water1
Following severe traumatic or thermal injury to the dermis, hypertrophic scars (HTSs) often develop in humans.
These scar fibroblasts (hypertrophic scar fibroblasts (HTSFs)) retain the myofibroblast phenotype persistently,
rather than transiently as in acute wounds. These pathogenic myofibroblasts constitutively express smooth-
muscle cell a-actin (SMAA), deposit an excessive amount of extracellular matrix (ECM) proteins, are highly
contractile, and stably display large focal adhesions. Increasing evidence supports a mechanism in which
autocrine production and activation of transforming growth factor-b1 (TGF-b1) are required to maintain the
pathogenic myofibroblast phenotype. We recently reported that Hic-5, a focal adhesion protein that is
upregulated by TGF-b1, is expressed persistently in HTSF compared to normal adult fibroblasts (NADFs). We
now find that Hic-5 is an important regulator of the constitutive myofibroblast phenotype in HTSFs. Silencing
the expression of Hic-5 in HTSFs with specific siRNAs dramatically reduces TGF-b1 production, decreases the
generation of supermature focal adhesions reduces expression of SMAA and decreases collagen contraction
and ECM synthesis. Our findings demonstrate that Hic-5 is an essential component of the mechanism regulating
autocrine production of TGF-b1 and the resulting pathogenic myofibroblast phenotype.
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INTRODUCTION
Fibrotic diseases, whether in the skin or other organs, are a
pathogenic form of scar formation in which excessive
deposition and contraction of extracellular matrix proteins
can dramatically reduce organ function and compromise
cosmetic appearance (Wynn, 2007). Scar formation, whether
normal or pathogenic, is driven by myofibroblasts, a cell type
differentiated from quiescent fibroblasts in a process that
requires transforming growth factor-b1 (TGF-b1) and me-
chanical stress (Tomasek et al., 2002; Hinz, 2007). While
myofibroblast differentiation during normal acute wound
healing is temporally limited, in fibrotic settings these
myofibroblasts persist in relatively high numbers for long
periods following injury. Hypertrophic scars (HTSs), one form
of cutaneous fibrotic disorder, develop after thermal or
traumatic injury to the deep dermis (Tuan and Nichter,
1998). Histological examination of HTSs shows distinct
nodules containing fine collagen fibers and an excessive
number of smooth-muscle cell a-actin (SMAA)-positive
myofibroblasts (hypertrophic scar fibroblasts (HTSFs)) (Ehrlich
et al., 1994). HTSF persistence is thought to occur as a
consequence of the autocrine production and activation of
TGF-b1 (Scott et al., 2000; Tredget et al., 2000).
This putative mechanism for TGF-b1 is likely important in
a broader spectrum of fibrotic disorders (Blobe et al., 2000).
However, the mechanism through which the TGF-b1 auto-
crine loop controls the pathogenic myofibroblast phenotype
remains largely unresolved. We recently reported that
cultured fibroblasts derived from HTSFs stably exhibit an
autocrine TGF-b1 loop that promotes assembly and main-
tenance of large focal adhesions, structures mediating
adhesion, collagen contraction and serving as intracellular
signaling centers (Dabiri et al., 2006). An intriguing potential
connection between focal adhesions and TGF-b1 regulation
led us to hypothesize that Hic-5 was important in the HTSF
phenotype.
Hic-5 is a TGF-b and H2O2-inducible focal adhesion
protein that serves as a transcription cofactor for p21Cip1,
c-fos, PPAR-g, and a coactivator for androgen receptors and
glucocorticoid receptors (Shibanuma et al., 1997, 2003;
Thomas et al., 1999; Yang et al., 2000; Kim-Kaneyama et al.,
2002). Hic-5 is unique among focal adhesion proteins
because it can shuttle between focal adhesions and the
nucleus in response to oxidants such as H2O2 (Shibanuma
et al., 2003). Given these properties, we recently reported
that Hic-5 is expressed constitutively by HTSFs and induced
by TGF-b1 in normal adult dermal fibroblasts (NADFs).
Moreover, Hic-5 is both necessary and sufficient to mediate
TGF-b1-regulated cell-cycle progression in NADFs and
HTSFs (Dabiri et al., 2008).
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In this study, we directly tested whether or not Hic-5 was
required for the generation of the myofibroblast phenotype by
analyzing SMAA expression, focal adhesion maturation,
extracellular matrix (ECM) synthesis, and collagen contrac-
tion in NADFs. To test the extent to which Hic-5 was required
for persistence of the HTSF phenotype, we employed genetic
silencing, finding that Hic-5 ‘‘knockdown’’ with RNA
interference reversed the myofibroblast phenotype of HTSFs
to that of a resting fibroblast phenotype. We also found that
Hic-5 was required to maintain the autocrine loop of TGF-b1
in HTSFs by regulating TGF-b1 production. Thus, Hic-5 is
upregulated by TGF-b1 and, in turn, is required for
production of TGF-b1 in a feed-forward mechanism in which
TGF-b1 levels remain constitutively high, thereby maintain-
ing the pathogenic myofibroblast phenotype.
RESULTS
Hic-5 is necessary for maintenance of supermature focal
adhesions in HTSFs
HTSFs persistently express a higher percentage of supermature
focal adhesions (X6mm2) per cell compared with NADFs. The
persistence of these focal adhesions in HTSFs was maintained
by elaboration of an autocrine loop generating active TGF-b1,
since inhibition of TGF-b1 significantly decreased the area of
focal adhesions in HTSFs (Dabiri et al., 2006). We sought to
determine how TGF-b1 maintained these supermature focal
adhesions in HTSFs. To do so, either Hic-5 or control short
interference RNAs (siRNAs) were transfected into either HTSFs
or NADFs. Cells were then trypsinized and cultured in the
presence or absence of TGF-b1 (10 ngml1) for 5 days. These
cells were fixed, stained with anti-vinculin, and the areas of
focal adhesion were measured (Figure 1). Western blot
analysis of Hic-5 was also performed to determine whether
or not the siRNAs to Hic-5 were effective in decreasing Hic-5
levels in NADFs and HTSFs (Figure 2b). We also observed by
immunofluorescence that greater than 90% of the cells
transfected with Hic-5 RNA interference lost Hic-5 staining
(data not shown). We found that 20% of the focal adhesions in
HTSFs measured greater than 6mm2 compared with approxi-
mately 7% seen in NADFs using vinculin immunofluorescent
staining. The addition of TGF-b1 to NADFs resulted in a
marked increase in the percentage of focal adhesions
measuring greater than 6mm2. Upon genetic silencing
of Hic-5 in HTSFs, a significant decrease in the percentage
of focal adhesions measuring greater than 6 mm2 was
observed. Since TGF-b1 regulates the size of focal adhesions,
we wanted to determine whether or not Hic-5 was necessary
for this TGF-b1-dependent effect. In the absence of Hic-5,
addition of TGF-b1 increased the size of focal adhesions to
levels comparable to that of control siRNA in the presence of
TGF-b1 in NADFs. Interestingly, in the absence of Hic-5, but
with the addition of exogenous TGF-b1 to HTSFs, focal
adhesion areas were restored to those of control HTSFs.
Although decreasing the area of focal adhesions, genetic
silencing of Hic-5 in HTSFs did not alter the overall levels of
vinculin or paxillin expressed (data not shown). These results
indicated that for both NADFs and HTSFs, Hic-5 was not
necessary for the TGF-b1-mediated generation of supermature
focal adhesions. However in HTSFs, Hic-5 was important for
the constitutive presence of supermature focal adhesions.
Hic-5 is important for maintenance of SMAA expression but not
generation of SMAA by TGF-b1
TGF-b1 is important in the transition from fibroblast to
myofibroblast, and in culture this differentiation occurs over
the course of 5 days (Desmoulie`re et al., 1993). Since we
found earlier that Hic-5 is regulated by TGF-b1, and that Hic-5
is important for the constitutive presence of supermature
focal adhesions in HTSFs, it was of interest to determine
whether Hic-5 levels are maintained during the course of the
5-day transition from a fibroblast to differentiated myofibro-
blast. Either NADFs or HTSFs were cultured in serum-free
media for 5 days with or without addition of TGF-b1
(10 ngml1) or anti-TGF-b1 (20 mgml1). We found that
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Figure 1. Hic-5 helps to maintain the persistence, but not generation, of
supermature focal adhesions. Cells were transfected (5 days) with either
siRNA to Hic-5 or scrambled control (see Materials and Methods). Cells were
then trypsinized and replated in medium containing serum for 18 hours,
washed, and cultured in serum-free medium either with or without addition of
TGF-b1 (5 days). Cells were then stained for vinculin (green) and stress fibers
(red). Percent focal adhesions greater than 6 mm2 were calculated as the ratio
between the total number of focal adhesions greater than 6 mm2 and the total
number of focal adhesions multiplied by 100. *Po0.005, n¼3. Bar¼ 10 mm.
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HTSFs were constitutively myofibroblastic, expressing SMAA
persistently; Hic-5 expression was also maintained in HTSFs
during 5 days in serum-free media (Figure 2a). With addition
of TGF-b for 5 days, both SMAA and Hic-5 were upregulated
in NADFs to levels comparable to HTSF control. Addition of
anti-TGF-b1 to HTSF cultures decreased the expression of
both Hic-5 and SMAA (Figure 2a), indicating that the
autocrine loop of TGF-b1 maintained the expression levels
of both SMAA and Hic-5. Since Hic-5 regulated the
maintenance, but not generation, of supermature focal
adhesions in HTSFs, and as there is a link between SMAA,
intracellular tension, and focal adhesion development (Hinz,
2007), we next determined whether inhibition of Hic-5
regulated SMAA expression. Either Hic-5 or control siRNAs
were transfected into HTSFs and NADFs for 5 days. Cells
were trypsinized and replated in serum-free medium in the
presence or absence of TGF-b1 (10 ngml1) for 5 days. We
found that genetic silencing of Hic-5 decreased the expres-
sion of SMAA in HTSFs. In NADFs or HTSFs treated with Hic-5
siRNA, TGF-b1 was still able to increase the expression of
SMAA to levels as high as those of HTSF controls (Figure 2b).
Cells were also immunostained for SMAA to ensure that the
differences in protein expression levels observed by western
blotting (Figure 2b) correlated with SMAA assembled into
stress fibers (data not shown). We found that approximately
80% of the HTSFs were SMAA-positive and that inhibition of
Hic-5 decreased the percentage of SMAA-positive cells by
eightfold to 10%. The addition of TGF-b1 to HTSFs in
which Hic-5 was genetically ablated resulted in a fivefold
increase in the percentage of SMAA-positive cells. In NADFs,
addition of TGF-b1 increased the percentage of SMAA-
positive cells by sevenfold and in the absence of Hic-5,
addition of TGF-b1 was still able to increase SMAA to levels
comparable to those of NADF control siRNA. These
results suggest a mechanism in which Hic-5 is required to
maintain persistent SMAA expression in HTSFs, but is
not required to initiate differentiation of fibroblasts to
myofibroblasts.
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Figure 2. Hic-5 maintains the expression of SMAA in HTSFs, but TGF-b1 is necessary for initiating fibroblast differentiation. (a) Cells without siRNA
transfection were trypsinized and replated (18 hours) in serum-containing medium, washed, and cultured (5 days) in serum-free medium either with or without
addition of TGF-b1 (10 ngml1) or anti-TGF-b1 (20mgml1). Cells were then lysed and directly resolved by SDS–PAGE (10%) and analyzed by western blotting.
The intensity of each band was normalized, first for differences in protein loading using Erk1/2, and then to HTSFs for each condition. Data from replicate
experiments were pooled and presented relative to HTSF control (n¼ 4). (b) Cells were transfected (5 days) as described under Materials and Methods. Cells
were then trypsinized and replated in medium containing serum (18 hours), washed, and cultured (5 days) in serum-free medium either with or without TGF-b
(10 ngml1). Cell lysates were plated, applied to SDS–PAGE gels (10%), analyzed by western blotting, and quantitated as described above. *Po0.005, n¼ 3.
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Figure 3. Hic-5 maintains the ability of HTSFs to contract collagen and produce ECM proteins. Cells were transfected (5 days) with siRNA as described under
Materials and Methods. (a) NADFs or (b) HTSFs were then trypsinized and cultured in a collagen lattice, rimmed, and covered with serum-free medium for 3
days. The percent from initial diameter was measured as the ratio between the decrease in diameter and the original diameter at day 3 multiplied by 100.
*Po0.005, **Po0.05, n¼3. (c) Cells were transfected (5 days) with siRNA (see Materials and Methods) and cultured as described in Figure 2b. Cells were lysed
and lysates were resolved by SDS–PAGE (8%) and analyzed by western blotting. *Po0.005, n¼3.
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Figure 4. siRNA Hic-5 disrupts the autocrine loop of TGF-b1 in HTSFs. Cells were transfected (5 days) with siRNA (see Materials and Methods) and cultured as
described in Figure 2b. (a) Total RNA was isolated from HTSFs and reverse transcriptase-PCR was performed to compare TGF-b1 and glyceraldehyde-3-
phosphate dehydrogenase mRNA levels relative to untreated HTSFs, or (b) conditioned medium was collected from the samples without addition of TGF-b1 and
sandwich ELISA using antibody reactive with active TGF-b1 was performed on conditioned media to measure the amount of active TGF-b1 and the amount of
total TGF-b1 (acid-treated to activate latent-TGF-b1). Amounts of latent-TGF-b1 were determined by subtracting the levels of active TGF-b1 from total TGF-b1.
*Po0.005, n¼ 3.
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Hic-5 regulates the expression of ECM proteins and modulates
the ability of HTSFs to contract collagen
SMAA-positive fibroblasts are important in wound closure
due to their ability to contract the matrix, a function that has
been modeled in vitro using collagen contraction assays
(Grinnell, 1994). Since knocking down the expression of Hic-5
decreased SMAA levels, we wanted to determine whether or
not inhibition of Hic-5 disrupted the ability of HTSFs to
contract collagen. Either Hic-5 or control siRNA were
transfected into either HTSFs or NADFs. Cells were trypsi-
nized and cultured in serum-free medium in the presence or
absence of TGF-b1 (10 ngml1) for 5 days. Cells were then
cultured in a floating collagen lattice for 3 days (Figures 3a
and b) or in an attached collagen lattice (data not shown).
Western blots were performed on cell lysates to confirm that
siRNA to Hic-5 was effective in decreasing Hic-5 levels in
NADFs and HTSFs (Figure 3c). We found that HTSFs
contracted collagen more extensively (threefold) compared
with NADF in a floating collagen lattice (Figures 3a and b)
and in an attached collagen lattice (not shown). As with the
floating collagen lattice, inhibiting the autocrine loop of TGF-b1
in HTSFs significantly decreased their ability to contract an
attached collagen lattice compared with the control (Dabiri
et al., 2006). The addition of TGF-b1 to NADFs decreased the
collagen diameter by threefold, comparable (Figure 3a) to the
contraction observed with HTSFs treated with control siRNA
(Figure 3b). When Hic-5 was silenced in NADFs in the
presence of TGF-b1, they were still able to contract collagen
(Figure 3a). Knocking down the expression of Hic-5 resulted
in a decrease in the ability of HTSFs to contract collagen
(Figure 3b). However, addition of TGF-b1 rescued the ability
of HTSFs to contract collagen (Figure 3b). These data indicate
that Hic-5 is not necessary to support the hypercontractile
state of HTSFs provided sufficient active TGF-b is present.
TGF-b1 induces the expression of collagen and fibronectin
(FN) in fibroblasts and Hic-5 overexpression increases the
mRNA levels of certain ECM proteins (Shibanuma et al.,
1997). We next tested whether or not Hic-5 regulates the
expression of FN and collagen type I in HTSFs and/or NADFs
(Figure 3c). Either Hic-5 or control siRNA was transfected into
HTSFs or NADFs and cells were trypsinized and cultured in
the presence or absence of TGF-b1 (10 ngml1) for 5 days.
We found that compared with NADFs, HTSFs expressed
approximately threefold more collagen and total FN. These
experiments were conducted in serum-free medium; thus, the
total FN levels measured comprised cellular FNs; blotting
with an antibody to the EIIIA (ED-A) FN segment confirmed
its presence, characteristic of cellular FN (not shown).
Inhibiting the autocrine loop of TGF-b1 in HTSFs significantly
decreased the expression of both collagen and total FN (data
not shown). The addition of TGF-b1 significantly increased
the expression of these ECM proteins in NADFs to levels
comparable to those in HTSFs. Interestingly, treatment of
HTSFs with Hic-5 siRNAs resulted in a decrease in collagen
and total FN expression. The addition of TGF-b1 to NADFs in
the absence of Hic-5 did not increase the expression of
collagen, but did significantly increase the expression of total
FN, albeit not to control levels, indicating that Hic-5 is
required for the TGF-b1 induction of collagen (Figure 3c).
However, partial restoration of FN expression by TGF-b1 in
the absence of Hic-5 indicates that FN expression may be
regulated by two pathways: one dependent upon, and the
other independent of, Hic-5.
These experiments tested the role of Hic-5 in maintaining
and establishing the HTSF phenotype. We were also
interested in testing whether or not Hic-5 was sufficient to
cause differentiation of fibroblasts to myofibroblasts without
the presence of TGF-b1. To test this, NADFs were infected
with adenoviral constructs expressing either green fluorescent
protein (GFP) control or GFP-Hic-5 for 5 days in serum-free
medium, as described previously (Dabiri et al., 2008). We
found that NADFs in which Hic-5 was overexpressed were
unable to increase either size of focal adhesions or expression
of SMAA; neither did they induce contraction of collagen nor
increased the expression of collagen or FN (not shown).
These results indicated that Hic-5 was not sufficient to drive
the fibroblast to myofibroblast differentiation. However,
Hic-5 was necessary to maintain HTSFs in a constitutive
myofibroblastic phenotype.
Hic-5 regulates the autocrine loop of TGF-b1 in HTSFs
When we silenced Hic-5 with specific siRNA in HTSFs, these
pathogenic cells reverted to a lesser, differentiated fibroblast
phenotype, and addition of TGF-b1 caused differentiation of
these resting fibroblasts back to a myofibroblast phenotype,
suggesting that Hic-5 could be regulating the autocrine
loop of TGF-b1 in HTSFs. Either Hic-5 or control siRNAs
were transfected into HTSFs; cells were then trypsinized
and replated in serum-free medium for 5 days with or without
addition of TGF-b1 (10 ngml1). Conditioned medium
was then collected from cells not treated with exogenous
TGF-b1. RNA was isolated from all cells and reverse
transcriptase-PCR was performed to compare the mRNA
levels of TGF-b1. We found that knocking down Hic-5
resulted in decreased TGF-b1 mRNA levels (Figure 4). The
addition of exogenous TGF-b1 did not increase TGF-b1’s
own mRNA expression (Figure 4a). To test TGF-b1 protein
levels, conditioned medium was assayed using a sandwich
ELISA. We found that the amount of both active and total
(obtained after acid activation of the conditioned media) was
decreased in the siRNA Hic-5-transfected HTSFs (Figure 4b).
Our findings demonstrated that autocrine production of TGF-b1
was regulated by Hic-5. We also tested whether or not
overexpressing Hic-5 had any effect on TGF-b1 production,
secretion, or activation. NADFs were transduced with GFP-
Hic-5 or GFP-control for 5 days in serum free conditions, and
RNA and conditioned medium was isolated after the fifth day.
Overexpressing Hic-5 increased the mRNA levels of TGF-b1
and the amount of secreted latent TGF-b1, but it did not
increase the amount of active TGF-b1 (data not shown).
These results demonstrate that Hic-5 is both necessary and
sufficient to regulate the production, but not activation, of
TGF-b1.
We conclude that Hic-5 is necessary for maintaining the
perpetual myofibroblast phenotype seen in HTSFs by virtue of
its regulation of endogenous TGF-b1 production. However, it
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is not sufficient to drive fibroblast differentiation to myofi-
broblast in NADFs. These data identify Hic-5 as a critical
component of the mechanism through which the autocrine
loop in HTSFs is maintained resulting in the pathogenesis of
HTSs.
DISCUSSION
TGF-b1 is a critical regulator of myofibroblast generation and
function, and we, and others, postulate that myofibroblast’s
persistence in fibrotic lesions results from the self-production
and activation of TGF-b1 through an ‘‘autocrine loop’’
(Dabiri et al., 2006, 2008; Hinz, 2007). Tredget et al.
(2000) reported that hypertrophic scar tissues and fibroblasts
produce more TGF-b1 mRNA and protein than normal skin
and cells. We determined that autocrine production of TGF-b1
in HTSFs resulted in constitutively larger focal adhesion
compared with in NADFs (Dabiri et al., 2006). These larger
adhesions mediated tighter binding to plasma FN and
enhanced collagen contraction to a greater extent in HTSFs
compared with that in NADFs. Recently, we reported that
persistent TGF-b1 expression through an autocrine loop
slowed HTSF cell proliferation (Dabiri et al., 2008).
In this study, we identify a critical element, the focal
adhesion protein Hic-5, in the autocrine production of TGF-b1,
which supports the persistent myofibroblast phenotype seen
in HTSFs. Genetic silencing with Hic-5 results in attenuation
of the autocrine production of TGF-b1 in HTSFs; a
pronounced reduction in focal adhesion areas in HTSFs;
decreased collagen contraction; and reduction to baseline
levels of SMAA, collagen I, and FN. Our data demonstrate
that Hic-5 is an essential element in the mechanism driving
autocrine TGF-b1 production. Interestingly, forced expres-
sion of Hic-5 in NADFs was not sufficient to promote
myofibroblast differentiation, but did increase the steady-
state levels of TGF-b1 mRNA. Accordingly, these cells
secreted significantly more latent-TGF-b1, but did not
increase the levels of active TGF-b1 in the conditioned
medium (data not shown). These data indicate that Hic-5 is
directly involved in regulating latent TGF-b1 expression,
whereas its role in regulating TGF-b1 activation is unknown.
Taken together, our data suggest a working model in which
myofibroblast differentiation is initiated by active TGF-b
produced by other cell types (for example, macrophages)
during the early phases of wound healing. However, active
TGF-b also induces Hic-5 production, which under patho-
genic conditions induces endogenous TGF-b production,
which when activated, promotes an autocrine loop main-
taining the pathogenic phenotype.
Hic-5 is upregulated in cells undergoing an epithelial-to-
mesenchymal cell transition and is necessary for this
phenotypic conversion (Tumbarello et al., 2005; Tumbarello
and Turner, 2007). Forced overexpression of Hic-5 in the
mammary epithelial cell line, MCF10A, led to disruption of
the cortically arranged actin and the development of ROCK-
dependent stress fibers, indicative of a contractile mesenchy-
mal phenotype (Tumbarello and Turner, 2007). Silencing
Hic-5 mRNA with specific siRNAs suppressed TGF-b1-
dependent RhoA activation during epithelial-to-mesenchy-
mal cell transition. However, we found that in the absence of
Hic-5, with addition of TGF-b1, NADFs could still differ-
entiate into a myofibroblast and, conversely, that over-
expressing Hic-5 in NADFs was not sufficient to cause
fibroblast differentiation (Figure 2b and data not shown).
Therefore, we hypothesize that Hic-5 is required to properly
regulate a set of Rho modulators (guanine exchange factors
and GTPase activating proteins) necessary for epithelial-to-
mesenchymal cell transition that are distinct from those
required for myofibroblast differentiation. This hypothesis has
important implications for epithelial-to-mesenchymal cell
transition during tumor progression and as a potential source
of fibroblasts at sites of tissue injury.
Our earlier work established that an autocrine loop exists
for TGF-b1 production and activation in HTSFs, and that this
autocrine loop regulates the proliferation of these pathogenic
myofibroblasts in a Hic-5-dependent mechanism (Dabiri
et al., 2006, 2008). We now report that Hic-5 is required to
maintain the autocrine loop of TGF-b1 that, in turn, supports
the persistent myofibroblast phenotype seen in HTSFs.
Importantly, we find that the TGF-b1-dependent autocrine
loop is disrupted when Hic-5 is knocked down, resulting in
reversion of these myofibroblasts to a more normal fibroblast
phenotype. Adding back active TGF-b1 to RNA interference-
treated HTSFs restores most myofibroblast functions (Figures
1–3), but not the autocrine loop (Figure 4). Our data suggest
that Hic-5 is an important new target in HTSFs, and
potentially other pathogenic myofibroblasts, that could be
inhibited therapeutically to help in the treatment of cuta-
neous fibrosis and possible other fibrotic disorders.
MATERIALS AND METHODS
Cell culture
All cells used in these studies were cultured (37 1C, 5% CO2) in
serum-containing media, which consisted of DMEM, 10% fetal
bovine serum, and 1% penicillin–streptomycin (all of which were
obtained from Gibco Invitrogen Corporation, Carlsbad, CA). NADFs
were purchased and HTSFs were isolated as described previously
(Dabiri et al., 2008). HTS tissues were acquired anonymously under
protocols approved by the relevant medical and ethical committees
of the Shriners Burn Center in accordance with the Declaration of
Helsinki Principles, and patients gave written, informed consent.
Western blot
NADF and HTSF lysates were analyzed for protein expression by
western blotting with the following primary antibodies at a
concentration of 1:1000: vinculin (Sigma Aldrich, St Louis, MO),
SMAA (Sigma Aldrich), FN 7.1, specific for the synergy site (III9)
present with FN (Neomarkers, Fremont, CA), collagen type I (Sigma
Aldrich), paxillin (Sigma Aldrich), Hic-5 (BD Transduction, Franklin
Lakes, NJ), and ERK1/2 (Santa Cruz Biotechnology, Santa Cruz, CA).
Western blots were developed as described previously (Dabiri et al.,
2008).
RNA interference
NADFs or HTSFs were transfected with siRNA (Dharmacon,
Lafayette, CO) using OligofectAMINE (Invitrogen, Carlsbad, CA).
Hic-5 knockdown was performed initially using a pool of four
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siRNAs; the pool was deconvolved and two specific siRNAs to Hic-5
were employed, duplex no. 1 (GGAGCUGGAUAGACUGAUGUU)
and duplex no. 2 (GGACCAGUCUGAAGAUAAGUU). Hic-5
knockdown both with the pooled (data not shown) and the
individual siRNAs (duplex no. 2, data not shown) resulted in a
greater than 90% decrease in the expression of Hic-5 in both NADFs
and HTSFs under basal conditions. In addition, all results using both
duplexes were similar. Cells were transfected in OptiMem (Gibco
Invitrogen Corporation) without serum for 4 hours. An equal volume
of DMEM with serum was added and culturing was continued for 5
days. Cells were then sub-cultured for experiments as designated in
the figure legends.
Reverse transcriptase-PCR
Total RNA was extracted from cells using the PURESCRIPT RNA
Isolation kit (Gentra Systems, Minneapolis, MN). RNA (one-tenth)
was reverse transcribed and 1mg of the resulting cDNA was used to
detect mRNA abundance with primers for TGF-b (forward:
50-GTACCTGAACCCGTGTTGCT, reverse: 50-GAACCCGTTGATG
TCCACTT), Hic-5 (forward 50-GCTAGATCGGTTGCTTCAGG,
reverse 50-GCGGAAGTCAGAGAGTGAGG), and glyceraldehyde-
3-phosphate dehydrogenase as control (forward: 50-CATGGCCTC
CAAGGAGTAAG, reverse: 50-GGTTGSGCACAGGGTACTTTA). All
primers were designed to give B200–350-bp products. PCRs were
carried out as previously described (Dabiri et al., 2008).
Collagen lattice
Before preparing the gels, 5ml of BSA (Sigma Aldrich) solution (0.1%
BSA in phosphate-buffered saline, filter sterilized) was pipetted into
each well of a six-well plate and incubated at 37 1C for 1 hour. A 1.4-
ml volume of bovine dermal collagen, Vitrogen (Cohesion,
Palo Alto, CA), was mixed with 0.4ml of 5 DMEM in a 15-ml
centrifuge tube cooled on ice. The pH was adjusted to a range of 7.2
to 7.5, using a sterile solution of 1 N NaOH. Either Hic-5 or control
siRNAs were transfected into either HTSFs or NADFs. Cells were
trypsinized and cultured in serum-free medium in the presence or
absence of TGF-b1 (10 ngml1) for 5 days. The control and modified
cells were trypsinized and 0.2ml of the cell suspension (containing
2.5 105 cells) was added to the collagen solution, gently mixed,
and poured. Collagen lattices were allowed to gel for 60minutes
under a 5% CO2 atmosphere at 37 1C. After 60minutes, the collagen
lattices were detached from the surface of the well by rimming the
lattice with a sterile spatula and gently swirling the six-well plate. A
2-ml volume of serum-free medium was added to each well. Plates
were incubated under a 5% CO2 atmosphere at 37 1C. To measure
contraction, the tissue culture dishes were placed on top of a
transparent metric ruler on an opaque background, and the
diameters of the lattices were recorded.
Immunofluorescence
Cells were stained as previously described (Dabiri et al., 2006), with
slight modification. Control or modified cells were cultured at 30%
confluence in complete medium for 18 hours, then washed with
Dulbecco’s phosphate-buffered saline, and serum-free medium was
added, followed by addition of 10 ngml1 of TGF-b1 or 20 mgml1
of anti-TGF-b1 (R&D Systems, Minneapolis, MN) where specified.
Cells were allowed to incubate for 5 days. On the fifth day, cells
were washed fixed, permeabilized, and blocked for 1 hour. The
samples were then incubated sequentially with mAbs
against vinculin (1:400; Sigma Chemical Co., St Louis, MO) and
then with a mixture of goat anti-mouse Alexa Fluor 488 (1:1000)
and TRITC-conjugated phalloidin (1:100). Coverslips were mounted
and the labeled cells were observed with an Olympus BX60
microscope equipped with an oil-immersion objective ( 100/1.3,
phase 3). Images were captured with attached Cooke Sensicam
digital camera and deconvolved using Slidebook 3.0.10.3
software (FFTW licensed from Massachusetts Institute of Technology,
Cambridge, MA).
Focal adhesion measurements
Focal adhesion measurements were performed as described pre-
viously (Dabiri et al., 2006). In brief, cells (n¼ 20) were chosen that
were not in contact with any other cell and were well spread. The
results were observed using Olympus BX60 microscope equipped
with an oil-immersion objective ( 60/1.25, phase 3) and images
captured as described above. Vinculin staining was measured for
area (mm2) of focal adhesion using Image Pro-Plus version 4.5.1.26
(Media Cybermatic, Silver Spring, MD). The limits set for measure-
ment was 1–50 mm2 (6.34 pixels mm1).
Measurement of TGF-b1 levels by ELISA
Conditioned serum-free media from control and modified fibroblasts
were collected at the end of 5 days and the levels of TGF-b1
were measured by ELISA (R&D Systems). The antibodies used
in the ELISA kit are only able to detect TGF-b1 in its active
form; thus, samples were activated by acidification (HCl)
before ELISA to determine the amount of latent-TGF-b1 in the
conditioned media (total measured TGF-b1active TGF-b1 levels).
After collecting the conditioned media, cells were treated
with trypsin, counted, and the values of TGF-b1 were normalized
by the ratio between the volume of medium in the dish and the final
cell number.
Statistics
Statistical comparisons between sample groups were made using an
analysis of variance with Pp0.005, indicating significant difference
between the groups.
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